Literature DB >> 23024987

NICE guidance on abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimen.

Matthew Dyer, Fiona Rinaldi, Elisabeth George, Amanda I Adler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23024987     DOI: 10.1016/s1470-2045(12)70289-9

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  A Systematic Review of Clinical Practice Guidelines for Castration-Resistant Prostate Cancer.

Authors:  Mohamad Javad Foroughi Moghadam; Saeed Taheri; Farzad Peiravian
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

2.  Realities in cost-effectiveness analyses: a study of castration-resistant prostate cancer patients using a medical claims database.

Authors:  Susumu Kunisawa; Chihiro Tange; Kojiro Shimozuma
Journal:  Springerplus       Date:  2015-10-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.